Back to 
BlackRock, Inc.
BlackRock, Inc.
MLTX7 quarters
Position history for BlackRock, Inc.'s holdings in MOONLAKE IMMUNOTHERAPEUTICS
BlackRock, Inc. holds 1.1M shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS), worth $21.3M as of 2026-Q2. The position was increased (+7.1% shares). MLTX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$21.3M
Current Shares
1.1M
Total Value Change
+$1.3M
Total Shares Change
+725,946
Quarter-by-Quarter History
Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/